SLS Competitors & Alternatives
Compare Sellas Life Sciences Group Inc with similar stocks in the same industry
Biotechnology
SLS
Main Stock$12.01
Tradestie Score
53
Market Cap
$211.22M
Revenue Growth
-0.8%
Analyst Upside
+129.0%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.29
|
$2.37B | - | 58 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$134.84
|
$2.35B | - | 55 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.64
|
$2.34B | - | 52 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$77.44
|
$2.33B | - | 57 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$32.27
|
$2.33B | - | 50 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.22
|
$2.23B | - | 56 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.93
|
$2.22B | - | 56 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$61.32
|
$2.21B | - | 61 | Compare |
More SLS Analysis
Data updated: Aug 08, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry